Transcode Therapeutics Inc (RNAZ)

Transcode Therapeutics Inc Azioni (RNAZ) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	18.97% 3.289	4.059	5.3275	5.1308	4.9011
Interest Income/Expense	0.00971	-	-	-	-
Operating Income/Loss	18.97% -3.289	-4.059	-5.3275	-5.1308	-4.9011
Nonoperating Income/Loss	32.68% -0.0378	-0.0285	0.0276	0.7892	0.0842
Income/Loss From Continuing Operations Before Tax	18.61% -3.3268	-4.0875	-5.30	-4.3417	-4.8169
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	18.61% -3.3268	-4.0875	-5.30	-4.3417	-4.8169
Net Income/Loss	18.61% -3.3268	-4.0875	-5.30	-4.3417	-4.8169
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	436.13% 5.1424	-1.5299	3.1572	1.3195	14.40
Diluted Average Shares	436.13% 5.1424	-1.5299	3.1572	1.3195	14.40
Basic Earnings Per Share	99.32% -0.65	-95.15	-1.68	-3.29	-0.33
Diluted Earnings Per Share	99.32% -0.65	-95.15	-1.68	-3.29	-0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-